A Phase II Trial Tetrathiomolybdate (TM), a Copper Depleting Compound, and Its Effect on Circulating Endothelial Progenitor Cells (EPCs) in Patients with Breast Cancer (BC) at High Risk of Recurrence.

Author(s):  
L. Vahdat ◽  
M. Ward ◽  
E. Chuang ◽  
T. Cigler ◽  
A. Moore ◽  
...  
2019 ◽  
Vol 32 (3) ◽  
pp. 770
Author(s):  
AsmaaS Abo El-Yazeed ◽  
LailaM Montaser ◽  
AhmedA Sonbol ◽  
AhmedS EL-Gammal

Sign in / Sign up

Export Citation Format

Share Document